Edition:
India

Tibet Rhodiola Pharmaceutical Holding Co (600211.SS)

600211.SS on Shanghai Stock Exchange

31.55CNY
19 Jul 2019
Change (% chg)

¥-0.19 (-0.60%)
Prev Close
¥31.74
Open
¥31.74
Day's High
¥32.05
Day's Low
¥31.42
Volume
579,648
Avg. Vol
1,745,983
52-wk High
¥44.30
52-wk Low
¥24.65

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2019 Mar '19 297.08 0.394
FY 2018 Dec '18 286.59 -0.087
Sep '18 288.44 0.565
Jun '18 240.11 0.340
Mar '18 212.74 0.382
FY 2017 Dec '17 272.95 0.422
Sep '17 207.21 0.426
Jun '17 189.79 0.022
Mar '17 245.67 0.301
 
*Note: Units in Millions ofRenminbi
**Note: Units in Renminbi

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Year Ending Dec-19 1 1,380.00 1,380.00 1,380.00 1,330.50
Year Ending Dec-20 1 1,761.00 1,761.00 1,761.00 1,657.50
Earnings (per share)
Year Ending Dec-19 1 1.99 1.99 1.99 1.93
Year Ending Dec-20 1 2.60 2.60 2.60 2.42
Sales and Profit Figures in China Yuan Renminbi (CNY);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) 30.58 29.88 32.66
P/E High - Last 5 Yrs. 259.96 42.96 47.28
P/E Low - Last 5 Yrs. 39.75 23.36 23.87
Beta 0.36 0.89 0.89
Price to Sales (TTM) 7.45 6.26 7.92
Price to Book (MRQ) 3.75 5.26 5.38
Price to Tangible Book (MRQ) 10.96 5.93 6.71
Price to Cash Flow (TTM) -- 23.51 24.37
% Owned Institutions -- 0.75 1.45

Dividends

  Company industry sector
Dividend Yield 0.82 1.42 1.35
Dividend Yield - 5 Year Avg 0.22 1.45 1.38
Dividend 5 Year Growth Rate -- 3.90 4.54
Payout Ratio(TTM) 0.00 42.62 40.25

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 22.09 5.12 12.23
Sales (TTM) vs TTM 1 Yr. Ago 36.20 6.49 7.74
Sales - 5 Yr. Growth Rate -5.88 10.59 10.88
EPS (MRQ) vs Qtr. 1 Yr. Ago -93.39 40.64 43.00
EPS (TTM) vs TTM 1 Yr. Ago 50.35 -- --
EPS - 5 Yr. Growth Rate 57.41 9.79 10.32
Capital Spending - 5 Yr. Growth Rate 33.08 15.44 14.84

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 1.98 2.11 2.21
Current Ratio (MRQ) 2.09 2.93 3.03
LT Debt to Equity (MRQ) 32.93 7.95 10.21
Total Debt to Equity (MRQ) 35.23 11.64 14.56
Interest Coverage (TTM) -- 32.88 29.24

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 71.54 51.83 52.21
Gross Margin - 5 Yr. Avg. 29.58 49.67 50.41
EBITD Margin (TTM) 25.52 -- --
EBITD - 5 Yr. Avg 6.87 17.40 13.16
Operating Margin (TTM) 21.62 13.79 6.88
Operating Margin - 5 Yr. Avg. 5.26 13.96 8.96
Pre-Tax Margin (TTM) 22.40 12.42 6.08
Pre-Tax Margin - 5 Yr. Avg. 6.44 14.37 9.26
Net Profit Margin (TTM) 20.14 9.21 2.71
Net Profit Margin - 5 Yr. Avg. 5.64 10.81 5.63
Effective Tax Rate (TTM) 10.09 22.44 22.40
Effective Tax Rate - 5 Yr. Avg. 12.52 22.49 22.75

Efficiency

  Company industry sector
Revenue/Employee (TTM) 2,045,950 993,662,009 887,821,366
Net Income/Employee (TTM) 412,100 114,096,732 101,905,564
Receivable Turnover (TTM) 8.37 5.96 5.94
Inventory Turnover (TTM) 1.97 2.62 3.36
Asset Turnover (TTM) 0.35 0.97 0.94

Management Effectiveness

  Company industry sector
Return on Assets (TTM) 7.00 11.51 11.18
Return on Assets - 5 Yr. Avg. 6.91 12.96 12.34
Return on Investment (TTM) 12.47 14.90 14.49
Return on Investment - 5 Yr. Avg. 16.02 16.86 16.03
Return on Equity (TTM) 15.78 16.02 15.79
Return on Equity - 5 Yr. Avg. 17.09 17.66 17.01
  1 Year 3 Year 5 Year
Sales % -42.38 -17.17 -5.88
EPS (TTM) % 116.39 94.01 57.41
Dividend % -100.00 -- --
Note: Units in Millions of US Dollars

Performance for Tibet Rhodiola Pharmaceutical Holding Co

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 2.88%
# of Holders: 14
Total Shares Held: 5,180,229
3 Mo. Net Change: -29,580
# New Positions: 0
# Closed Positions: 1
# Increased Positions: 1
# Reduced Positions: 1
# Net Buyers: 0
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.